Teladoc ( ($TDOC) ) just unveiled an update. On December 9, 2025, Teladoc Health, Inc. amended its 2023 Employment Inducement Incentive Award Plan ...

HIMS expands its tech-driven care with new diagnostics, hormonal treatments, and a Canada launch via Livewell.

Barclays initiated coverage of Teladoc (TDOC) with an Equal Weight rating and $8.50 price target The firm started the U.S healthcare technology ...

If you have been wondering whether Teladoc Health is a beaten down bargain or a value trap, you are not alone, and this ...

The consensus rating for Phreesia is Outperform, based on 5 analyst ratings. With an average one-year price target of $33.8, there's a potential 64.48% upside.

Piper Sandler 37th Annual Healthcare Conference December 2, 2025 12:30 PM ESTCompany ParticipantsCharles Divita - CEO ...

The all-inclusive payment covers full-spectrum treatment along with wraparound support, including integrated medical care, ...

Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

About Teladoc Health Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — ...

Detailed price information for Teladoc Health Inc (TDOC-N) from The Globe and Mail including charting and trades.

Teladoc Health TDOC has been banking on acquisitions to boost growth, which has expanded its distribution capabilities, broadened its service offerings and created a global footprint. Its acquisition ...